Phase II study of oral ridaforolimus in patients with metastatic and/or locally advanced recurrent endometrial cancer: NCIC CTG IND 192. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Mackay, H
  • Welch, S
  • Tsao, MS
  • Biagi, JJ
  • Elit, Laurie
  • Ghatage, P
  • Martin, LA
  • Tonkin, KS
  • Ellard, S
  • Lau, SK
  • McIntosh, L
  • Eisenhauer, EA
  • Oza, AM

publication date

  • May 20, 2011